tetramethylpyrazine has been researched along with Degenerative Diseases, Central Nervous System in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Deng, C; Meng, S; Meng, Z | 1 |
| Chen, H; Meng, S; Meng, Z | 1 |
1 review(s) available for tetramethylpyrazine and Degenerative Diseases, Central Nervous System
| Article | Year |
|---|---|
The Roles of Tetramethylpyrazine During Neurodegenerative Disease.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Humans; Neurodegenerative Diseases; Pyrazines; Vasodilator Agents | 2021 |
1 other study(ies) available for tetramethylpyrazine and Degenerative Diseases, Central Nervous System
| Article | Year |
|---|---|
Tetramethylpyrazine ameliorates systemic streptozotocin-induced Alzheimer-like pathology.
Topics: Alzheimer Disease; Animals; Disease Models, Animal; Hippocampus; Mice; Neurodegenerative Diseases; Neuroprotective Agents; Oxidative Stress; Streptozocin | 2023 |